Filana Therapeutics, Inc. Common Stock (FLNA) is a publicly traded the market company. As of July 26, 2026, FLNA trades at $0.89 with a market cap of $43.04M and a P/E ratio of 0.00. FLNA moved -4.43% today. Year to date, FLNA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.89 to $2.27. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces FLNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for FLNA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.89 |
| Market Cap | $43.04M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.27 |
| 52-Week Low | $0.89 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover FLNA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.